Related Experiment Video
Updated: Aug 17, 2026

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
Published on: July 17, 2016
Aminoglycoside nephrotoxicity: keys to prevention
1Division of Nephrology/Hypertension, Northwestern University Medical School, Chicago, USA.
Abstract:
The kidneys are the primary site of aminoglycoside clearance; any factor that permits renal parenchymal accumulation increases the risk of aminoglycoside nephrotoxicity. The most common underlying cause is excessive aminoglycoside administration (especially in women or elderly patients). To minimize the risk of nephrotoxicity, select loading and maintenance aminoglycoside dosages based on estimated creatinine clearance. Also, monitor peak and trough serum aminoglycoside levels, replenish volume, and correct potassium and magnesium abnormalities. If possible, avoid giving aminoglycosides to patients with hepatic dysfunction or to those receiving other nephrotoxic drugs or radiocontrast agents.
Insights
Aminoglycoside nephrotoxicity risk increases with kidney accumulation. Proper dosing based on creatinine clearance and monitoring serum levels can minimize this risk, especially in vulnerable patients.
Area of Science:
- Nephrology
- Pharmacology
- Internal Medicine
Background:
- Kidneys are the main organs for aminoglycoside drug clearance.
- Renal parenchymal accumulation of aminoglycosides elevates nephrotoxicity risk.
- Over-administration, particularly in women and the elderly, is a common cause.
Purpose of the Study:
- To outline strategies for minimizing aminoglycoside-induced kidney damage.
- To emphasize the importance of individualized dosing and therapeutic drug monitoring.
Main Methods:
- Dose selection guided by estimated creatinine clearance.
- Monitoring of peak and trough serum aminoglycoside concentrations.
- Management of fluid balance and electrolyte abnormalities (potassium, magnesium).
Main Results:
- Individualized aminoglycoside dosing based on renal function is crucial.
- Therapeutic drug monitoring aids in preventing toxic accumulation.
- Avoiding concurrent use with nephrotoxic agents is recommended.
Conclusions:
- Optimizing aminoglycoside therapy requires careful consideration of renal function and drug levels.
- Proactive management strategies can significantly reduce the incidence of aminoglycoside nephrotoxicity.
More Related Videos
07:38Induction of Nephrotic Syndrome in Mice by Retrobulbar Injection of Doxorubicin and Prevention of Volume Retention by Sustained Release Aprotinin
Published on: May 6, 2018
06:24Effective and Safe Gene Delivery to the Mouse Kidney via Slow Retrograde Renal Pelvis Injection of Adeno-Associated Virus Vectors
Published on: August 1, 2025
Related Concept Videos
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Pharmacokinetics in Pediatric Patients: Drug Excretion
Kidney Transplant III: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care